Akynzeo or Olanzapine for Patients Who Experience Breakthrough CINV in Patient Receiving Moderately or Highly Emetogenic Chemotherapy After First Cycle of Chemotherapy
The purpose of the proposed study is to provide a clinical approach to chemotherapy induced nausea and vomiting (CINV) prophylaxis in cycle 2 of moderately emetogenic chemotherapy or highly emetogenic chemotherapy for patients who developed breakthrough CINV after cycle 1 based on the available data in the literature as well as the recommendations provided by established guidelines
100 项与 Simon-Williamson Clinic PC 相关的临床结果
0 项与 Simon-Williamson Clinic PC 相关的专利(医药)
100 项与 Simon-Williamson Clinic PC 相关的药物交易
100 项与 Simon-Williamson Clinic PC 相关的转化医学